VMP 42274811000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mirtazapine 45mg tablets
BNF code 0403040X0AAAPAP
Virtual Therapeutic Moiety Mirtazapine
Date identifier became valid 22 Sep 2023
Previous product identifier 375196006
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Mirtazapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 45.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mirtazapine 45mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Accord-UK Ltd)
Mirtazapine 45mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 45mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 45mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 45mg tablets (Medreich Plc)
Mirtazapine 45mg tablets (Milpharm Ltd)
Mirtazapine 45mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 45mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 45mg tablets (Relonchem Ltd)
Mirtazapine 45mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Mirtazapine 45mg tablets 28 tablet
Mirtazapine 45mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback